🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

👀 how do I get on the list for this my friends? Jeremy Brooksbank Dennis Narcisse Alex Sullivan

Incredibly fortunate to have the opportunity to work with such an incredible mentor Krina Patel! I would also like to thank International Myeloma Foundation for organizing such an exceptional conference, and for supporting the endeavors of young investigators!

Very grateful to have such an amazing mentor/sponsor Krina Patel! Thank you to all members of the US MM Cellular Therapy Consortium for your contributions and for the opportunity to present our data. Looking forward to future collaborations! #ASH22

I’d come back for one last dance on 9300 as a trainee to round with Matt Labriola and Dr. Galanos. Both are on the Mount Rushmore of Duke Marines! Dr. AimeeZaasDukeIMPD Duke IM Residency

In the CARTITUDE-4 trial, patients with lenalidomide-refractory multiple myeloma who received ciltacabtagene autoleucel (cilta-cel) had significantly longer progression-free survival than those who received standard therapy. View full results: nej.md/3MKxpfq #ASCO23

How much did you have to pay him to say this? American Board of Internal Medicine (ABIM)

Did you give her a nice honorarium check to write this propaganda, or did you buy her the RV? American Board of Internal Medicine (ABIM)

Delete your account American Board of Internal Medicine (ABIM)

How Firm Thy Friendship!!!!

A possible game-changer for those battling relapsed/refractory multiple myeloma (RRMM). 🩸Our study shows that 33% of patients treated with cilta-cel have remained progression-free for ≥5 years. #ASCO25 Link: bit.ly/4koE3aX